Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Deargen
company
About
Deargen provides AI-based genome analysis service.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $17M
- Industries
- Artificial Intelligence,Biotechnology,Machine Learning
- Founded date
- Dec 6, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Deargen provides AI-based genome analysis service.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$17M
Deargen has raised a total of
$17M
in funding over 2 rounds. Their latest funding was raised on
Feb 24, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 24, 2022 | Series B | $17M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Deargen is funded by 1 investors.
Nvestor (Korea)
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
